Literature DB >> 20233947

Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR.

Lihua He1, Luba A Aleksandrov, Liying Cui, Timothy J Jensen, Kenneth L Nesbitt, John R Riordan.   

Abstract

Deletion of PHE508 (DeltaF508) from the first nucleotide-binding domain (NBD1) of CFTR, which causes most cystic fibrosis, disrupts the folding and assembly of the protein. Although the folding pathways and yield of isolated NBD1 are altered, its global structure is not, and details of the changes in the rest of the protein remain unclear. To gain further insight into how the whole mutant protein is altered, we have determined the influence of known second-site suppressor mutations in NBD1 on the conformation of this domain and key interfaces between domains. We found that the suppressors restored maturation of only those processing mutations located in NBD1, but not in other domains, including those in the C-terminal cytoplasmic loop of the second membrane-spanning domain, which forms an interface with the NBD1 surface. Nevertheless, the suppressors promoted the formation of this interface and others in the absence of F508. The suppressors restored maturation in a DeltaF508 construct from which NBD2 was absent but to a lesser extent than in the full-length, indicating that DeltaF508 disrupts interactions involving NBD2, as well as other domains. Rescue of DeltaF508-CFTR by suppressors required the biosynthesis of the entire full-length protein in continuity, as it did not occur when N- and C-terminal "halves" were coexpressed. Simultaneous with these interdomain perturbations, DeltaF508 resulted in suppressor reversed alterations in accessibility of residues both in the F508-containing NBD1 surface loop and in the Q loop within the domain core. Thus, in the context of the full-length protein, DeltaF508 mutation causes detectable changes in NBD1 conformation, as well as interdomain interactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233947      PMCID: PMC2909275          DOI: 10.1096/fj.09-141788

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

1.  Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.

Authors:  L Aleksandrov; A Mengos; X Chang ; A Aleksandrov; J R Riordan
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

2.  F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.

Authors:  Tamás Hegedus; Andrei Aleksandrov; Liying Cui; Martina Gentzsch; Xiu-Bao Chang; John R Riordan
Journal:  Biochim Biophys Acta       Date:  2006-03-31

3.  Cooperative assembly and misfolding of CFTR domains in vivo.

Authors:  Kai Du; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

4.  Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator.

Authors:  Hal A Lewis; Sean G Buchanan; Stephen K Burley; Kris Conners; Mark Dickey; Michael Dorwart; Richard Fowler; Xia Gao; William B Guggino; Wayne A Hendrickson; John F Hunt; Margaret C Kearins; Don Lorimer; Peter C Maloney; Kai W Post; Kanagalaghatta R Rajashankar; Marc E Rutter; J Michael Sauder; Stephanie Shriver; Patrick H Thibodeau; Philip J Thomas; Marie Zhang; Xun Zhao; Spencer Emtage
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

5.  Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.

Authors:  H A Lewis; C Wang; X Zhao; Y Hamuro; K Conners; M C Kearins; F Lu; J M Sauder; K S Molnar; S J Coales; P C Maloney; W B Guggino; D R Wetmore; P C Weber; J F Hunt
Journal:  J Mol Biol       Date:  2009-11-26       Impact factor: 5.469

6.  The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator.

Authors:  Eva Y Chen; M Claire Bartlett; Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

7.  Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

8.  Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508.

Authors:  Ana C V DeCarvalho; Lisa J Gansheroff; John L Teem
Journal:  J Biol Chem       Date:  2002-07-10       Impact factor: 5.157

Review 9.  CFTR function and prospects for therapy.

Authors:  John R Riordan
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

10.  Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating.

Authors:  Lihua He; Andrei A Aleksandrov; Adrian W R Serohijos; Tamás Hegedus; Luba A Aleksandrov; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

View more
  41 in total

1.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

2.  Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter.

Authors:  Silvere Pagant; John J Halliday; Christos Kougentakis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

3.  Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.

Authors:  Zhengrong Yang; Chi Wang; Qingxian Zhou; Jianli An; Ellen Hildebrandt; Luba A Aleksandrov; John C Kappes; Lawrence J DeLucas; John R Riordan; Ina L Urbatsch; John F Hunt; Christie G Brouillette
Journal:  Protein Sci       Date:  2014-05-03       Impact factor: 6.725

4.  Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis.

Authors:  Emily F Kirby; Ashley S Heard; X Robert Wang
Journal:  J Pharmacol Clin Toxicol       Date:  2013-08-28

5.  Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

Authors:  Wael M Rabeh; Florian Bossard; Haijin Xu; Tsukasa Okiyoneda; Miklos Bagdany; Cory M Mulvihill; Kai Du; Salvatore di Bernardo; Yuhong Liu; Lars Konermann; Ariel Roldan; Gergely L Lukacs
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

Review 6.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

7.  Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator.

Authors:  Chi Wang; Andrei A Aleksandrov; Zhengrong Yang; Farhad Forouhar; Elizabeth A Proctor; Pradeep Kota; Jianli An; Anna Kaplan; Netaly Khazanov; Grégory Boël; Brent R Stockwell; Hanoch Senderowitz; Nikolay V Dokholyan; John R Riordan; Christie G Brouillette; John F Hunt
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

8.  The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.

Authors:  Hanneke Hoelen; Bertrand Kleizen; Andre Schmidt; John Richardson; Paraskevi Charitou; Philip J Thomas; Ineke Braakman
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochemistry       Date:  2010-08-03       Impact factor: 3.162

10.  Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.

Authors:  Justin T Marinko; Hui Huang; Wesley D Penn; John A Capra; Jonathan P Schlebach; Charles R Sanders
Journal:  Chem Rev       Date:  2019-01-04       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.